These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6312217)
41. The application of molecular biology to the development of novel vaccines. Kniskern PJ; Hagopian A; Burke P; Dunn N; Montgomery DL; Schultz LD; Schulman CA; Carty CE; Maigetter RZ; Wampler DE Adv Exp Med Biol; 1989; 251():83-98. PubMed ID: 2532858 [TBL] [Abstract][Full Text] [Related]
42. Immunogenicity and protective efficacy in a rhesus monkey model of vaccine Ac NFUi(S-) MRC against primary type 2 herpes simplex virus infection. Skinner GR; Buchan A; Williams D; Marsden J; Hartley C; Wilbanks G; Turyk M; Namkoong ES Br J Exp Pathol; 1982 Aug; 63(4):378-87. PubMed ID: 6295430 [TBL] [Abstract][Full Text] [Related]
43. DNA sequence of the major capsid protein gene of herpes simplex virus type 1. Davison AJ; Scott JE J Gen Virol; 1986 Oct; 67 ( Pt 10)():2279-86. PubMed ID: 3020164 [TBL] [Abstract][Full Text] [Related]
44. Prospects for new viral vaccines. Marmion BP Philos Trans R Soc Lond B Biol Sci; 1980 Aug; 290(1040):395-407. PubMed ID: 6106250 [TBL] [Abstract][Full Text] [Related]
45. ts P1 and P3 genes are responsible for satisfactory level of attenuation of ts-1A2 recombinants bearing H1N1 or H3N2 surface antigens of influenza A virus. Massicot JG; Murphy BR; van Wyke K; Huang KY; Chanock RM Virology; 1980 Oct; 106(1):187-90. PubMed ID: 6893373 [No Abstract] [Full Text] [Related]
46. [Infection defense antigens against pathogenic viruses to human. Infection defense antigens and genetic code--trend and progress of study on biomolecular analysis. b. Herpes simplex virus]. Kenichi U Nihon Rinsho; 1987 Oct; 45(10):2235-8. PubMed ID: 2834573 [No Abstract] [Full Text] [Related]
48. Viral vaccines under development: a third generation. Osborn JE Adv Exp Med Biol; 1979; 118():61-82. PubMed ID: 227237 [TBL] [Abstract][Full Text] [Related]
50. The hepatitis B virus. Tiollais P; Pourcel C; Dejean A Nature; 1985 Oct 10-16; 317(6037):489-95. PubMed ID: 2995835 [TBL] [Abstract][Full Text] [Related]
51. Application of molecular genetics to the design of live herpes simplex virus vaccines. Roizman B; Warren J; Thuning CA; Fanshaw MS; Norrild B; Meignier B Dev Biol Stand; 1982; 52():287-304. PubMed ID: 6299836 [TBL] [Abstract][Full Text] [Related]
52. Expression in bacteria of gB-glycoprotein-coding sequences of Herpes simplex virus type 2. Person S; Warner SC; Bzik DJ; Debroy C; Fox BA Gene; 1985; 35(3):279-87. PubMed ID: 2412940 [TBL] [Abstract][Full Text] [Related]